Annis Gardner Whiting Capital Advisors’s Profound Medical PROF Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$259K	Buy	+40,000	New	+$276K	0.04%	277

Other funds holding PROF

Fidelity International

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Z3 Capital Partners Richmond, Virginia $395M AUM

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's PROF Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors opened a new position in Profound Medical (PROF) in Q1 2026: 40,000 shares worth $259K. The stake represents 0.04% of the portfolio and ranks #277 among its holdings.

57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

Annis Gardner Whiting Capital Advisors held 40,000 shares of Profound Medical worth $259K as of Q1 2026.
Profound Medical was a new Annis Gardner Whiting Capital Advisors position in Q1 2026.
Profound Medical made up 0.04% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #277 holding.
57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.